Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02080715Phase 1Completed
Phase 1, randomised, double-blind trial in sleep deprivation comparing Tolcapone with Placebo (2 arms). Primary endpoint: Evolution of vigilance during prolonged wakefulness at 2 weeks. Started Jun 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02080715.